Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal
OptiNose, Inc. (OPTN)
Last optinose, inc. earnings: 3/5 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.optinose.com
Company Research
Source: GlobeNewswire
YARDLEY, Pa., June 19, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has been named one of the Philadelphia Business Journal’s “Best Places to Work” for 2019 in the medium-sized company category. “From the very start of Optinose in 2010, we believed that hiring great people and creating a work environment in which those people can come together and accomplish even greater things together should be our highest priority,” said Peter Miller, CEO of Optinose. “We are excited to be recognized as a ‘Best Place to Work’ by the Philadelphia Business Journal for the second year in a row and our goal is that each colleague loves coming to work every day.” “Receiving public recognition of Optinose as a ‘Best Place to Work’ is an honor, and it is only possible because of the quality and commitment of our colleagues,” added Ramy Mahmoud, MD, President
Show less
Read more
Impact Snapshot
Event Time:
OPTN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPTN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPTN alerts
High impacting OptiNose, Inc. news events
Weekly update
A roundup of the hottest topics
OPTN
News
- Optinose to Present at the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target [Yahoo! Finance]Yahoo! Finance
- OptiNose, Inc. (NASDAQ: OPTN) had its price target lowered by analysts at Piper Sandler from $3.00 to $1.00. They now have an "overweight" rating on the stock.MarketBeat
- OptiNose, Inc. (NASDAQ: OPTN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.MarketBeat
- OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance [Yahoo! Finance]Yahoo! Finance
OPTN
Earnings
- 8/8/24 - Beat
OPTN
Analyst Actions
- 11/13/24 - HC Wainwright
OPTN
Sec Filings
- 12/18/24 - Form 4
- 12/18/24 - Form 4
- 12/17/24 - Form 144
- OPTN's page on the SEC website